These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 35669436)
1. Identification of the Putative Tumor Suppressor Characteristics of FAM107A Ou D; Zhang Z; Wu Z; Shen P; Huang Y; She S; She S; Lin ME Front Oncol; 2022; 12():861281. PubMed ID: 35669436 [TBL] [Abstract][Full Text] [Related]
2. FAM107A as a Tumor Suppressor in Bladder Cancer Inhibits Cell Proliferation, Migration, and Invasion. Ou L; Wei Z; Xu J; Li W; Zhou Y; Wang Y; Shi B Ann Clin Lab Sci; 2022 Mar; 52(2):260-268. PubMed ID: 35414505 [TBL] [Abstract][Full Text] [Related]
3. FAM107A Inactivation Associated with Promoter Methylation Affects Prostate Cancer Progression through the FAK/PI3K/AKT Pathway. Ke S; Liu Z; Wang Q; Zhai G; Shao H; Yu X; Guo J Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010909 [TBL] [Abstract][Full Text] [Related]
4. Transcription factor SP1-induced microRNA-146b-3p facilitates the progression and metastasis of colorectal cancer via regulating FAM107A. Wang D; Feng M; Ma X; Tao K; Wang G Life Sci; 2021 Jul; 277():119398. PubMed ID: 33831429 [TBL] [Abstract][Full Text] [Related]
5. Identification of FAM107A as a potential biomarker and therapeutic target for prostate carcinoma. Ma YF; Li GD; Sun X; Li XX; Gao Y; Gao C; Cao KX; Yang GW; Yu MW; Wang XM Am J Transl Res; 2021; 13(9):10163-10177. PubMed ID: 34650688 [TBL] [Abstract][Full Text] [Related]
6. Combined deletion and DNA methylation result in silencing of FAM107A gene in laryngeal tumors. Kiwerska K; Szaumkessel M; Paczkowska J; Bodnar M; Byzia E; Kowal E; Kostrzewska-Poczekaj M; Janiszewska J; Bednarek K; Jarmuż-Szymczak M; Kalinowicz E; Wierzbicka M; Grenman R; Szyfter K; Marszałek A; Giefing M Sci Rep; 2017 Jul; 7(1):5386. PubMed ID: 28710449 [TBL] [Abstract][Full Text] [Related]
7. Loss of family with sequence similarity 107, member A (FAM107A) induces browning in 3T3-L1 adipocytes. Manigandan S; Mukherjee S; Yun JW Arch Biochem Biophys; 2021 Jun; 704():108885. PubMed ID: 33878327 [TBL] [Abstract][Full Text] [Related]
8. A Comprehensive Analysis of the Glutathione Peroxidase 8 (GPX8) in Human Cancer. Ren Z; He Y; Yang Q; Guo J; Huang H; Li B; Wang D; Yang Z; Tian X Front Oncol; 2022; 12():812811. PubMed ID: 35402257 [TBL] [Abstract][Full Text] [Related]
9. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. Wang N; Zhu L; Wang L; Shen Z; Huang X Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736 [TBL] [Abstract][Full Text] [Related]
10. A Pan-Cancer Analysis of UBE2S in Tumorigenesis, Prognosis, Pathway, Immune Infiltration and Evasion, and Therapy Response from an Immune-Oncology Perspective. Bao H; Luo Y; Ding G; Fu Z J Oncol; 2022; 2022():3982539. PubMed ID: 35578600 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma. Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL Front Immunol; 2021; 12():781087. PubMed ID: 35069553 [TBL] [Abstract][Full Text] [Related]
12. Decreased FAM107A Expression in Patients with Non-small Cell Lung Cancer. Pastuszak-Lewandoska D; Czarnecka KH; Migdalska-Sęk M; Nawrot E; Domańska D; Kiszałkiewicz J; Kordiak J; Antczak A; Górski P; Brzeziańska-Lasota E Adv Exp Med Biol; 2015; 852():39-48. PubMed ID: 25753555 [TBL] [Abstract][Full Text] [Related]
13. Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression. Chen X; Yuan Y; Ren W; Zhou F; Huang X; Pu J; Niu X; Jiang X Front Oncol; 2022; 12():927988. PubMed ID: 35756681 [TBL] [Abstract][Full Text] [Related]
14. Integrative Pan-Cancer Analysis Confirmed that FCGR3A is a Candidate Biomarker Associated With Tumor Immunity. Li L; Huang Z; Du K; Liu X; Li C; Wang D; Zhang Y; Wang C; Li J Front Pharmacol; 2022; 13():900699. PubMed ID: 35668930 [No Abstract] [Full Text] [Related]
15. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer. Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606 [TBL] [Abstract][Full Text] [Related]
16. Immune Infiltration of MMP14 in Pan Cancer and Its Prognostic Effect on Tumors. Li M; Li S; Zhou L; Yang L; Wu X; Tang B; Xie S; Fang L; Zheng S; Hong T Front Oncol; 2021; 11():717606. PubMed ID: 34604053 [TBL] [Abstract][Full Text] [Related]
17. Pan-Cancer Analysis Based on Zhang Y; Wang S; Han S; Feng Y Front Oncol; 2022; 12():844794. PubMed ID: 35359375 [TBL] [Abstract][Full Text] [Related]
18. A Pan-Cancer Analysis Revealing the Dual Roles of Lysine (K)-Specific Demethylase 6B in Tumorigenesis and Immunity. Ding JT; Yu XT; He JH; Chen DZ; Guo F Front Genet; 2022; 13():912003. PubMed ID: 35783266 [No Abstract] [Full Text] [Related]
19. Pan-cancer Analysis of NEDD4L and Its Tumor Suppressor Effects in Clear Cell Renal Cell Carcinoma. Dong H; Zhu L; Sun J; Zhang Y; Cui Q; Wu L; Chen S; Lu J J Cancer; 2021; 12(20):6242-6253. PubMed ID: 34539897 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuria. Xu Y; Kim YH; Jeong P; Piao XM; Byun YJ; Kang HW; Kim WT; Lee JY; Kim IY; Moon SK; Choi YH; Yun SJ; Kim WJ Urol Oncol; 2019 Jan; 37(1):86-96. PubMed ID: 30446454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]